Bladder Cancer Highlights Webcasts

AUA2017 Webcasts

Independent educational grant support provided by:

  • Astellas
  • Merck
  • Olympus Corporation of the Americas

Prime Time Friday Morning

AUA Guidelines 2017: Muscle Invasive Bladder Cancer

Speaker: Jeffrey M. Holzbeierlein, MD

Play Video 1  


Next Frontier Saturday Morning

Journal of Urology 2016: Top Papers: Bladder and Renal Cancer

Speaker: Badrinath R. Konety, MD

Play Video 1   Play Video 2 ESP   Listen Audio 2 ESP   Listen   


Prime Time Sunday Afternoon

Surgical Techniques: Endoscopic Diagnosis and Transurethral Resection of Superficial Bladder Cancer

Speaker: Mitchell R. Humphreys, MD

Play Video 1   Play Video 2 ESP   Listen    Listen  ESP  


Next Frontier Monday Morning

State-of-the-Art Lecture: Immunotherapy for Bladder Cancer

Speaker: Peter C. Black, MD

Play Video 1   Play Video 2 ESP   Listen    Listen Audio 2 ESP  


Next Frontier Tuesday Morning

Complex Cases: Bladder Cancer

Speaker: Arthur I. Sagalowsky, MD

Play Video 1   Play Video 2 ESP   Listen    Listen Audio 2 ESP  


Next Frontier Tuesday Afternoon

Take Home Messages: Bladder Cancer

Speaker: Angela M. Smith, MD

Play Video 2   Play Video 1 ESP   Listen Audio 1 ESP   Listen Audio 2  


 

What Urologists Want to Know: Addressing Current Questions and Controversies Regarding the Role of Immune Checkpoint Inhibitors in the Management of Bladder Cancer

What Urologists Want to Know: Addressing Current Questions and Controversies Regarding the Role of Immune Checkpoint Inhibitors in the Management of Bladder Cancer

CME Play   

What Urologists Want to Know: Addressing Current Questions and Controversies Regarding the Role of Immune Checkpoint Inhibitors in the Management of Bladder Cancer - Satellite Symposia

Role of Immune Checkpoint Inhibitors in Locally Advanced or Metastatic Bladder Cancer: The Urologist's Perspective

Role of Immune Checkpoint Inhibitors in Locally Advanced or Metastatic Bladder Cancer: The Urologist's Perspective

CME Play   

Role of Immune Checkpoint Inhibitors in Locally Advanced or Metastatic Bladder Cancer: The Urologist's Perspective - Satellite Symposia